The Aurum Institute - The Aurum Institute

A Mixed-Method Evaluation of the Association Between Attitudes Toward Gender-Based Violence and Sexual Behaviors Among Adolescents and Young Adults in Rustenburg, South Africa

Fri, 09 Jan 2026 09:55:02 +0200

Makkan, H., Mlotshwa, M., Masibi, P., Molefe, T., Mthembu, F., Maenetje, P., Edward, V.A., Price, M.A., Chetty-Makkan, C., De Wit, J.B. and Lalla-Edward, S.T., 2026. A Mixed-Method Evaluation of the Association Between Attitudes Toward Gender-Based Violence and Sexual Behaviors Among Adolescents and Young Adults in Rustenburg, South Africa. AIDS and Behavior, pp.1-16.

Cardiac safety of bedaquiline, delamanid and moxifloxacin co-administered with or without varying doses of sutezolid or delpazolid for the treatment of drug-susceptible TB

Thu, 10 Jul 2025 14:07:23 +0200

Koele, S.E., Stoycheva, K., Mtweve, C., Manyama, C., Mpagama, S., Mhimbira, F., Wallis, R., Ntinginya, N.E., Liyoyo, A., Huglin, B. and Minja, L.T., 2025. Cardiac safety of bedaquiline, delamanid and moxifloxacin co-administered with or without varying doses of sutezolid or delpazolid for the treatment of drug-susceptible TB. Journal of Antimicrobial Chemotherapy, p.dkaf210.

A Prospective, Randomised, Open Label Phase 2b Dose-Finding Trial of Delpazolid in Combination with Bedaquiline, Delamanid and Moxifloxacin for Pulmonary Tuberculosis: DECODE

Wed, 09 Jul 2025 11:50:02 +0200

Minja, L.T., van der Feltz, I., Manyama, C., Mpagama, S., Mhimbira, F., Noreña, I., Sebe, M., Rassool, M., Wallis, R., Ntinginya, N.E. and Liyoyo, A., A Prospective, Randomised, Open Label Phase 2b Dose-Finding Trial of Delpazolid in Combination with Bedaquiline, Delamanid and Moxifloxacin for Pulmonary Tuberculosis: DECODE.

Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trial

Fri, 16 May 2025 11:46:38 +0200

Weld, E.D., Beattie, T., Moodley, J., Mapendere, M., Salles, I., Solans, B.P., Nonyane, B.A., Wiesner, L., Nielson, T., Edward, V.A. and Chihota, V., 2025. Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trial. The Lancet HIV.

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study

Fri, 11 Apr 2025 10:03:25 +0200

Garrett, N., Tapley, A., Hudson, A., Dadabhai, S., Zhang, B., Mgodi, N.M., Andriesen, J., Takalani, A., Fisher, L.H., Kee, J.J. and Magaret, C.A., 2025. Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study. EClinicalMedicine, 80.

Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art Review

Fri, 11 Apr 2025 09:56:47 +0200

Chihota, V., Gombe, M., Gupta, A., Salazar-Austin, N., Ryckman, T., Hoffmann, C.J., LaCourse, S., Mathad, J.S., Mave, V., Dooley, K.E. and Chaisson, R.E., 2024. Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art Review. Drugs, pp.1-21.

“Time to Change”: To What Extent Could Non-Sputum Sampling Accelerate the Fight Against Tuberculosis—A Qualitative Study Among End-Users

Fri, 11 Apr 2025 09:54:48 +0200

Fargnoli, V., Hanh, H.T.M., Hoang, L.N., Mahesh, A., Mqedlana-Ntombela, N., Xavier, J., Kohli, M., Velen, K. and Shilton, S., 2025. “Time to Change”: To What Extent Could Non-Sputum Sampling Accelerate the Fight Against Tuberculosis—A Qualitative Study Among End-Users. Tropical Medicine and Infectious Disease, 10(2), p.44.

BMI as a predictor of progression from TB infection to active TB in PLHIV.

Fri, 11 Apr 2025 09:52:53 +0200

Nguenha, D., Ndebele, F., Saavedra, B., Mambuque, E., Acácio, S., Cárdenas, V., Chihota, V., Grant, A., Yimer, G., Fielding, K. and Cobelens, F., 2025. BMI as a predictor of progression from TB infection to active TB in PLHIV. The International Journal of Tuberculosis and Lung Disease, 29(2), pp.54-59.

The potential impact of new TB vaccines on the burden of TB in people living with HIV in South Africa.

Fri, 11 Apr 2025 09:51:36 +0200

Sumner, T., Clark, R.A., Prys-Jones, T.O., Bakker, R., Churchyard, G. and White, R.G., 2022. The potential impact of new TB vaccines on the burden of TB in people living with HIV in South Africa. AIDS, pp.10-1097.

N-acetylcysteine modulates markers of oxidation, inflammation and infection in tuberculosis.

Fri, 11 Apr 2025 09:50:12 +0200

Mapamba, D.A., Sabi, I., Lalashowi, J., Sauli, E., Buza, J., Olomi, W., Mtafya, B., Kibona, M., Bakuli, A., Rachow, A. and Velen, K., 2025. N-acetylcysteine modulates markers of oxidation, inflammation and infection in tuberculosis. Journal of Infection, 90(2), p.106379.